Preventing Suicide in the Year Following Birth: Lessons from California
Study on maternal suicide reveals data to inform treatment, prevention
Pregnancy and childbirth — a time of joy? Not
For some mothers, pregnancy or managing a newborn can be exceptionally stressful. Depression or serious life events may amplify their distress and, though rare, may lead some to take their own lives.
Maternal suicide is preventable.
Join us to hear the results of a recent California survey of pregnancy-associated suicides. This study of nearly 100 suicides revealed important findings regarding key risk factors, the types of symptoms and warning signs prior to suicide, and the role of substance use as a contributing factor. Faculty will share their recommendations for access to care, evaluation, diagnosis, and treatment of perinatal mental health conditions.
Who should participate?
Perinatal services, quality improvement and patient safety and clinicians would all benefit.
- Review of California study of 99 suicides and important
- Risk factors (race, age, underlying mental health disorders)
- Timing of suicides relative to pregnancy or postpartum
- Type of psychiatric symptoms related to the suicide
- Contributing factor of substance use
- Impact of missing and inadequate psychological and psychiatric services
- Identification of critical warning signs
- Recommendations for changes in access, evaluation, diagnosis and treatment of perinatal mental health conditions
Date and Time
Thursday, November 17, 2020 from 11:00 am – 12:00 pm, Pacific Time
Click hereto register for this webinar.
Dr. Main has a 30-year career in maternal-fetal medicine and is Professor of Obstetrics and Gynecology at Stanford University. From its inception 10 years ago, Dr. Main has directed the California Maternal Quality Care Collaborative, better known as CMQCC. He also is the Chair of the California Pregnancy-Associated Mortality Review Committee.
Nationally, he serves as the Implementation Director for the Alliance for Innovation in Maternal Health (or AIM) initiative, the national multi-disciplinary project for the reducing maternal mortality based at ACOG. Nationally, he also has served or chaired committees on Maternal Quality measurement for ACOG, the AMA, The Joint Commission, Leap Frog and CMS. In 2013, Dr. Main received the ACOG Distinguished Service Award for his work in quality improvement.
Dr. Nirmaljit Dhami is the medical director of Inpatient perinatal psychiatry unit at El Camino Hospital. She has been the program director of the MOMS program since its inception in April 2008. She was instrumental in incorporating a novel, video-based mother baby attachment intervention in the program. She has created a new and comprehensive MOMS self-assessment tool. She is the past board member of the International Perinatal Marce society and has served as a panel member on the California Perinatal Mortality Task Force (CA- PMR).
She completed her residency in adult psychiatry from UCSD. She has completed a California Health Care Foundation sponsored fellowship in health care leadership from UCSF. Her interests include assessment and treatment of psychotic disorders in pregnancy and postpartum and perinatal suicide. She enjoys spending time with her family and swimming with US masters.
At the conclusion of the webinar attendees will be able to:
- Identify the timing and risk factors for perinatal suicides
- List the key suicide prevention opportunities identified in the large case review
- Identify key approaches for the care of women with severe mental illness in the postpartum period
One complimentary CE unit will be provided to dues-paying member hospitals of the Hospital Quality Institute, CHPSO, the California Hospital Association or the regional hospital associations in CA.
HQI is an approved continuing education (CE) provider by the California Board of Registered Nursing and will provide CHPSO members an opportunity to earn CEs. Provider Number CEP16793 for 1.0 contact hour.
HQI does not currently offer ACPE approved Pharmacy CE, but the State of California will accept CE from courses which have been approved for continuing education by the Medical Board of California, the California Board of Podiatric Medicine, the California Board of Registered Nursing or the Dental Board of California towards their California continuing education requirement (Section 1732.2(b) of the California Code of Regulations). Pharmacists need to keep track of CE from these sources on their own as they are not submitted to NAPB.